L-Tryptophan（CAS# 73-22-3)
| Nā hōʻailona pōʻino | Xi – Hoʻohaunaele |
| Nā Code Risk | R33 - ʻO ka pōʻino o nā hopena kumulative R40 - Nā hōʻike liʻiliʻi o ka hopena carcinogenic R62 - He pilikia paha o ka hoʻoulu ʻana R41 – Ka pilikia o ka poino nui i na maka R37/38 – Hoʻonanea i ka ʻōnaehana hanu a me ka ʻili. R36/37/38 – Hoʻonanea i ka maka, ka ʻōpū hanu a me ka ʻili. R22 – Poino ke aleia |
| Ka wehewehe palekana | S24/25 – Hōʻalo i ka pili ʻana me ka ʻili a me nā maka. S36/37/39 – E hoʻohana i nā lole pale kūpono, nā mīkina lima a me ka pale maka/maka. S36 – E komo i nā lole pale kūpono. S26 – Inā pili me nā maka, e holoi koke me ka wai nui a e ʻimi i ka ʻōlelo aʻo kino. |
| WGK Kelemānia | 2 |
| RTECS | YN6130000 |
| NUI FLUKA BRAND F | 8 |
| TSCA | ʻAe |
| HS Code | 29339990 |
| Kaʻawaʻawa | LD508mmol / kg (iole, intraperitoneal injection). He palekana ke hoʻohana ʻia i ka meaʻai (FDA, §172.320, 2000). |
Hoʻolauna
ʻO L-Tryptophan kahi waikawa amino chiral me kahi apo indole a me kahi pūʻulu amino i kona ʻano. ʻO ka mea maʻamau he pauka crystalline keʻokeʻo a melemele paha i hiki ke hoʻoheheʻe ʻia i ka wai a ua hoʻonui i ka solubility ma lalo o nā kūlana acidic. ʻO L-tryptophan kekahi o nā waikawa amino koʻikoʻi ʻaʻole hiki ke synthesized e ke kino o ke kanaka, he ʻāpana o nā protein, a he mea waiwai nui hoʻi i ka synthesis a me ka metabolism o nā protein.
ʻElua mau ala nui e hoʻomākaukau ai i ka L-tryptophan. Lawe ʻia kekahi mai nā kumu kūlohelohe, e like me nā iwi holoholona, nā huahana waiu, a me nā hua kanu. Hoʻopili ʻia ka mea ʻē aʻe e nā ala biochemical synthesis, me ka hoʻohana ʻana i nā microorganisms a i ʻole ka ʻenehana ʻenekinia genetic no ka synthesis.
Mālama ʻia ka L-tryptophan, akā loaʻa paha i ka lawe ʻana i nā hopena ʻaoʻao. Hiki i ka ʻai nui ke hoʻopilikia i ka ʻōpū, nausea, luaʻi, a me nā hopena ʻē aʻe. No kekahi mau maʻi, e like me ka poʻe me ka tryptophan hereditary kakaʻikahi i ka maʻi, hiki i ka ʻai ʻana i ka L-tryptophan ke hoʻoulu i nā pilikia olakino koʻikoʻi.
